Roen Surgical’s Kidney Stone Robot Zamenix Secures US FDA Clearance
Zamenix, a kidney stone surgery robot developed by medical robotics company Roen Surgical, has received Class II clearance from the U. S.
Search results for "Europe"
Global Asset Managers Expand Holdings in South Korean Pharma and Biotech
Major institutional asset managers are steadily increasing their equity stakes in South Korean pharmaceutical and biotechnology companies, drawn by...
Muscle 'Quality' Beats Quantity: Fat Infiltration Between Muscles Drives Colon Cancer Survival
"You need to eat well and build up your strength." Cancer patients and their families frequently hear this advice ahead...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
Prevention vs. Treatment: Why Cancer Therapy Demands a Completely Different Diet
What makes diabetes particularly dangerous is the risk of severe, systemic complications.
Asan Medical Center Performs South Korea’s First Artisse Implant to Seal Complex Brain Aneurysms
Treating a brain aneurysm presents steep clinical challenges when the lesion features a wide neck or develops at a...
Medical AI Can Explain Its Decisions—but Can Clinicians Trust Its Reasons?
Artificial intelligence in medical imaging can analyze brain magnetic resonance imaging scans not only to estimate...
Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market
Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines...
Beyond Soccer: How Buenos Aires Comforts and Heals the Soul
(Editor’s note) Travel is not only about taking in beautiful scenery. Sometimes, it drops you into a moment that feels...
Daegu Wins Bid to Host 2034 World Congress of Basic & Clinical Pharmacology
Daegu has been selected to host the 2034 World Congress of Basic & Clinical Pharmacology (WCP 2034), marking the first...